Related Experiment Videos
[Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis]
W F Gattaz1, J Brunner, A Schmitt
1Arbeitsgruppe Neurobiologie, Zentralinstitut für Seelische Gesundheit Mannheim.
Fortschritte Der Neurologie-Psychiatrie
|December 1, 1994
Summary
Schizophrenia patients exhibit elevated Phospholipase A2 (PLA2) activity, leading to accelerated membrane phospholipid breakdown. Animal studies show PLA2 inhibits dopaminergic pathways, suggesting a link to schizophrenia's neurobiology.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Phospholipase A2 (PLA2) is crucial for membrane phospholipid metabolism.
- Elevated PLA2 activity is observed in schizophrenia patients' serum and plasma.
- PLA2 activity can be reduced by neuroleptic treatment.
Purpose of the Study:
- To investigate the role of PLA2 in schizophrenia.
- To examine the effects of PLA2 on dopaminergic neurotransmission in rats.
Main Methods:
- Measured PLA2 activity, membrane phospholipids, and lysophosphatidylcholine (LPC) in schizophrenic patients.
- Administered intracerebral PLA2 injections into the substantia nigra pars compacta in rats.
- Assessed rotational behavior induced by dopamine agonists post-injection.
Main Results:
- Schizophrenic patients showed increased PLA2 activity, decreased phospholipids, and elevated LPC in platelets.
- Intranigral PLA2 injection in rats resulted in long-lasting inhibition of the nigrostriatal dopaminergic pathway.
- Apomorphine induced ipsilateral rotation, indicating reduced dopaminergic activity.
Conclusions:
- A subgroup of schizophrenic patients may have increased PLA2 activity, causing accelerated phospholipid breakdown.
- PLA2 inhibits dopaminergic activity in the brain, potentially contributing to schizophrenia pathophysiology.
- Findings suggest a link between altered phospholipid metabolism and dopaminergic dysfunction in schizophrenia.